Related Experiment Video
Updated: Mar 29, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Screening and Monitoring Before and During Systemic Therapy: Recommendations for Patients With Psoriasis
1University of Utah, Salt Lake City, Utah.
Abstract:
When patients with psoriasis are candidates for systemic therapy, the list of appropriate agents for each patient should be derived from careful patient and family history and selected laboratory screening protocols so that the potential risks associated with treatment can be minimized. Once a therapeutic choice is made, monitoring strategies also are necessary for early identification and intervention of adverse events that may arise. In addition to appropriate screening and monitoring protocols, communication between patient and clinician is essential to enhance the benefits of therapy and minimize the risks. Semin Cutan Med Surg 34(supp2):S40-S42 © 2015 published by Frontline Medical Communications.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Nephrotic Syndrome II : Assessment and Medical Management
Drug Therapy
Antianxiety Medications
Nephrotic Syndrome III : Nursing Management

